Literature DB >> 25480584

Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells.

Jian-Wei Huang1, Bao-Zhang Guan1, Liang-Hong Yin2, Fan-Na Liu1, Bo Hu1, Qi-Yi Zheng1, Fo-Lan Li1, Ying-Xue Zhong1, Yu Chen1.   

Abstract

Estrogen-related receptor alpha (ERRα) plays an important role in the development of hormone-dependent cancers, but its roles in lung cancer remain elusive. The present study was aimed to investigate the effects of ERRα on the proliferation and metastasis of lung cancer A549 cells. The mRNA and protein levels of ERRα were detected in lung cancer A549 and MCF-7 cells and bronchial epithelial BEAS-2B cells by qRT-PCR and Western blotting, respectively. ERRα plasmid transfection and XCT-790 (an inverse agonist of ERRα) were used to up-regulate or down-regulate ERRα expression in A549 cells, respectively. The viability of A549 cells was measured by cell counting kit-8 (CCK-8) and the motility of A549 cells by wound healing assay and Transwell migration/invasion assay. The epithelial markers E-cadherin (E-Cad) and zona occludin-1 (ZO-1), the mesenchymal markers fibronectin (FN) and vimentin (Vim) and the transcription factors (Snail, Zeb1 Twist and Slug) were further detected at mRNA and protein levels by qRT-PCR and Western blotting, respectively. The results showed that ERRα promoted the growth of lung cancer A549 cells in vitro. XCT-790 significantly inhibited the migration and invasion of A549 cells. Over-expression of ERRα promoted the epithelial-to-mesenchymal transition (EMT) of A549 cells, down-regulated the epithelial makers E-Cad and ZO-1, and up-regulated the mesenchymal makers FN and Vim. Silencing of Slug, but not other transcription factors, significantly abolished the ERRα-induced EMT of A549 cells. It was suggested that ERRα promoted the migration and invasion of A549 cells by inducing EMT, and Slug was involved in the process. Targeting ERRα might be an efficient approach for lung cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480584     DOI: 10.1007/s11596-014-1367-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  30 in total

Review 1.  Estrogen-related receptor alpha as a therapeutic target in cancer.

Authors:  R A Stein; D P McDonnell
Journal:  Endocr Relat Cancer       Date:  2006-12       Impact factor: 5.678

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 3.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

4.  Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha.

Authors:  J M Vanacker; C Delmarre; X Guo; V Laudet
Journal:  Cell Growth Differ       Date:  1998-12

5.  Targeting estrogen-related receptor alpha inhibits epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells.

Authors:  Sophia Sn Lam; Abby Sc Mak; Judy Wp Yam; Annie Ny Cheung; Hextan Ys Ngan; Alice St Wong
Journal:  Mol Ther       Date:  2014-01-14       Impact factor: 11.454

6.  Lung cancer mortality risk among breast cancer patients treated with anti-estrogens.

Authors:  Christine Bouchardy; Simone Benhamou; Robin Schaffar; Helena M Verkooijen; Gerald Fioretta; Hyma Schubert; Vincent Vinh-Hung; Jean-Charles Soria; Georges Vlastos; Elisabetta Rapiti
Journal:  Cancer       Date:  2011-01-24       Impact factor: 6.860

7.  Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity.

Authors:  Christie Eheman; S Jane Henley; Rachel Ballard-Barbash; Eric J Jacobs; Maria J Schymura; Anne-Michelle Noone; Liping Pan; Robert N Anderson; Janet E Fulton; Betsy A Kohler; Ahmedin Jemal; Elizabeth Ward; Marcus Plescia; Lynn A G Ries; Brenda K Edwards
Journal:  Cancer       Date:  2012-03-28       Impact factor: 6.860

8.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  ERRα metabolic nuclear receptor controls growth of colon cancer cells.

Authors:  Gérald Bernatchez; Véronique Giroux; Thomas Lassalle; André C Carpentier; Nathalie Rivard; Julie C Carrier
Journal:  Carcinogenesis       Date:  2013-05-29       Impact factor: 4.944

10.  Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers.

Authors:  Jiro Fujimoto; Eriko Sato
Journal:  J Steroid Biochem Mol Biol       Date:  2009-05-03       Impact factor: 4.292

View more
  15 in total

1.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  High expression of estrogen-related receptor α is significantly associated with poor prognosis in patients with colorectal cancer.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

3.  Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.

Authors:  Eunji Jo; Seong Ji Park; Yu Sun Choi; Woo-Kwang Jeon; Byung-Chul Kim
Journal:  Neoplasia       Date:  2015-07       Impact factor: 5.715

Review 4.  The Potential Role of Nitric Oxide in Halting Cancer Progression Through Chemoprevention.

Authors:  Huzefa Vahora; Munawwar Ali Khan; Usama Alalami; Arif Hussain
Journal:  J Cancer Prev       Date:  2016-03-30

5.  Alterations in exosomal miRNA profile upon epithelial-mesenchymal transition in human lung cancer cell lines.

Authors:  Yue-Ting Tang; Yi-Yao Huang; Jing-Huan Li; Si-Hua Qin; Yong Xu; Tai-Xue An; Chun-Chen Liu; Qian Wang; Lei Zheng
Journal:  BMC Genomics       Date:  2018-11-06       Impact factor: 3.969

6.  ERRα is an aggressive factor in lung adenocarcinoma indicating poor prognostic outcomes.

Authors:  Ping Li; Jian Wang; Desheng Wu; Xiaohu Ren; Wen Wu; Ran Zuo; Qingbo Zeng; Bingyu Wang; Xi He; Jianhui Yuan; Ni Xie
Journal:  Cancer Manag Res       Date:  2019-09-02       Impact factor: 3.989

7.  ERRα Regulates OTUB1 Expression to Promote Colorectal Cancer Cell Migration.

Authors:  Yi Zhou; Qingzhu Jia; Xiaoqing Meng; Diangang Chen; Bo Zhu
Journal:  J Cancer       Date:  2019-10-06       Impact factor: 4.207

8.  Antimetastatic effects of cordycepin mediated by the inhibition of mitochondrial activity and estrogen-related receptor α in human ovarian carcinoma cells.

Authors:  Chia-Woei Wang; Wei-Hsuan Hsu; Chen-Jei Tai
Journal:  Oncotarget       Date:  2017-01-10

9.  A novel fatty acid-binding protein 5-estrogen-related receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells.

Authors:  Shogo Senga; Koichiro Kawaguchi; Narumi Kobayashi; Akira Ando; Hiroshi Fujii
Journal:  Oncotarget       Date:  2018-08-03

Review 10.  Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer.

Authors:  Erika Di Zazzo; Giovanni Galasso; Pia Giovannelli; Marzia Di Donato; Antonio Bilancio; Bruno Perillo; Antonio A Sinisi; Antimo Migliaccio; Gabriella Castoria
Journal:  Cancers (Basel)       Date:  2019-09-23       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.